Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details)

v3.19.3.a.u2
Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Cash $ 2,518   $ 2,518   $ 6,994
Accounts receivable, net 352,761   352,761   97,581
Prepaid expenses and other current assets 6,867   6,867   35,777
Current assets classified as held for sale 362,146   362,146   140,352
Property and equipment, net 4,946   4,946   5,790
Deposits 6,029   6,029   6,029
Non-current assets classified as held for sale 10,975   10,975   11,819
Accounts payable (includes related parties) 1,225,124   1,225,124   1,079,827
Accrued expenses 1,207,484   1,207,484   939,183
Current portion of notes payable 268,851   268,851   278,836
Current liabilities classified as held for sale 2,701,459   2,701,459   2,297,846
Revenue from services 246,676 $ 512,566 766,627 $ 1,383,378  
Cost of services 26,012 45,641 113,266 133,738  
Gross profit (loss) 220,664 466,925 653,361 1,249,640  
Operating expenses 355,828 625,951 1,413,423 1,940,990  
Other (income) expense 2,912 404 31,874 (807,137)  
Provision for income taxes  
Loss from discontinued operations (138,076) (159,430) (791,936) 115,787  
Advanced Molecular Services Group [Member]          
Cash 220   220   4,471
Accounts receivable, net 22,523   22,523   6,838
Prepaid expenses and other current assets     25,477
Current assets classified as held for sale 22,743   22,743   36,786
Non-current assets classified as held for sale    
Accounts payable (includes related parties) 514,415   514,415   532,858
Accrued expenses 493,356   493,356   418,932
Income taxes payable    
Current portion of notes payable 268,851   268,851   278,836
Current liabilities classified as held for sale 1,276,622   1,276,622   1,230,626
Non-current liabilities classified as held for sale    
Revenue from services 11,350 13,249 59,832 92,090  
Cost of services 5,878 15,559 29,638 37,773  
Gross profit (loss) 5,472 (2,310) 30,194 54,317  
Operating expenses 60,424 93,059 237,042 363,944  
Other (income) expense 2,912 (5,748) 31,874 (819,258)  
Provision for income taxes  
Loss from discontinued operations (57,864) (89,621) (238,722) 509,631  
Health Technology Solutions, Inc [Member]          
Cash 2,298   2,298   2,523
Accounts receivable, net 330,238   330,238   90,743
Prepaid expenses and other current assets 6,867   6,867   10,300
Current assets classified as held for sale 339,403   339,403   103,566
Property and equipment, net 4,946   4,946   5,790
Deposits 6,029   6,029   6,029
Non-current assets classified as held for sale 10,975   10,975   11,819
Accounts payable (includes related parties) 710,709   710,709   546,969
Accrued expenses 714,128   714,128   520,251
Current portion of notes payable    
Current liabilities classified as held for sale 1,424,837   1,424,837   $ 1,067,220
Revenue from services 235,326 499,317 706,795 1,291,288  
Cost of services 20,134 30,082 83,628 95,965  
Gross profit (loss) 215,192 469,235 623,167 1,195,323  
Operating expenses 295,404 532,892 1,176,381 1,577,046  
Other (income) expense 6,152 12,121  
Provision for income taxes  
Loss from discontinued operations $ (80,212) $ (69,809) $ (553,214) $ (393,844)